• LAST PRICE
    1.9500
  • TODAY'S CHANGE (%)
    Trending Up0.0100 (0.5155%)
  • Bid / Lots
    1.9100/ 21
  • Ask / Lots
    2.0100/ 1
  • Open / Previous Close
    1.9500 / 1.9400
  • Day Range
    Low 1.8900
    High 2.0500
  • 52 Week Range
    Low 1.3000
    High 3.6200
  • Volume
    326,617
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 1.94
TimeVolumeCKPT
09:32 ET22781.9411
09:41 ET2001.95
09:43 ET12281.975
09:45 ET4001.985
09:48 ET15321.99
09:50 ET7801.99
09:52 ET20652.01
09:54 ET11502.005
09:56 ET14002.005
09:57 ET89812.005
09:59 ET28072.005
10:01 ET3002.015
10:03 ET5002.005
10:06 ET3002.005
10:08 ET1002.005
10:10 ET78162.03
10:12 ET2002.02
10:14 ET167812.04
10:15 ET22912.05
10:17 ET416421.951
10:24 ET2851.985
10:26 ET4711.985
10:30 ET40001.95
10:32 ET4001.975
10:33 ET1001.96
10:37 ET4011.98
10:44 ET3001.97
10:46 ET6001.98
10:53 ET1001.98
10:57 ET40001.97
11:02 ET31001.98
11:04 ET9961.99
11:08 ET1001.98
11:09 ET5651.98
11:11 ET66011.98
11:18 ET1001.99
11:22 ET17991.97
11:24 ET5001.97
11:36 ET87501.94
11:40 ET37901.95
11:45 ET1001.975
11:56 ET1001.99
11:58 ET10841.975
12:00 ET1001.975
12:02 ET35221.98
12:05 ET2601.965
12:07 ET2661.965
12:09 ET195531.94
12:16 ET7601.95
12:25 ET4001.96
12:27 ET59561.945
12:30 ET2001.945
12:32 ET3251.95
12:34 ET1001.95
12:36 ET1001.95
12:45 ET1001.95
12:56 ET53811.97
01:03 ET2001.97
01:08 ET7031.97
01:10 ET29151.97
01:12 ET51211.96
01:14 ET24741.95
01:17 ET25001.9438
01:19 ET26951.93
01:21 ET24421.92
01:24 ET46961.93
01:26 ET2001.925
01:35 ET3311.925
01:39 ET10001.928
01:42 ET7421.93
01:48 ET33011.96
01:50 ET3901.97
02:02 ET3001.97
02:04 ET1201.9501
02:09 ET8261.97
02:11 ET2001.97
02:13 ET2001.98
02:18 ET98941.99
02:22 ET2001.975
02:26 ET12001.99
02:27 ET10121.97
02:31 ET3001.99
02:33 ET1451.985
02:36 ET15002
02:38 ET33001.98
02:40 ET2001.99
02:42 ET3002
02:44 ET2001.99
02:45 ET14001.99
02:47 ET1002
02:49 ET1002
02:54 ET2001.99
02:58 ET4431.99
03:00 ET2002
03:02 ET52111.97
03:03 ET58591.95
03:09 ET2031.95
03:20 ET1001.95
03:23 ET1001.98
03:25 ET14691.965
03:32 ET3001.97
03:34 ET92121.94
03:36 ET358031.905
03:38 ET2001.93
03:39 ET2001.92
03:41 ET26521.94
03:43 ET1001.93
03:45 ET1001.94
03:48 ET24031.93
03:50 ET30071.96
03:52 ET6801.98
03:54 ET4211.975
03:56 ET138771.93
03:57 ET7001.95
03:59 ET9511.95
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCKPT
Checkpoint Therapeutics Inc
69.6M
-0.8x
---
United StatesBNTC
Benitec Biopharma Inc
69.5M
-0.8x
---
United StatesTIL
Instil Bio Inc
69.6M
-0.6x
---
United StatesALRN
Aileron Therapeutics Inc
70.0M
-1.0x
---
United StatesTPST
Tempest Therapeutics Inc
69.1M
-1.8x
---
United StatesCVM
CEL-SCI Corp
70.4M
-2.2x
---
As of 2024-06-11

Company Information

Checkpoint Therapeutics, Inc. is a clinical-stage immunotherapy and targeted oncology company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers. The Company is evaluating its lead antibody product candidate, cosibelimab, a potential best-in-class anti-programmed death-ligand 1 (PD-L1) antibody licensed from the Dana-Farber Cancer Institute, as a potential new treatment for patients with selected recurrent or metastatic cancers, including metastatic and locally advanced cutaneous squamous cell carcinoma. The Company is also evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer. Its anti-GITR monoclonal antibody, CK-302, is a fully human agonistic antibody that is designed to bind to and trigger signaling in GITR expressing cells.

Contact Information

Headquarters
95 SAWYER ROAD, SUITE 110WALTHAM, MA, United States 02453
Phone
781-652-4500
Fax
302-531-3150

Executives

Chairman of the Board
Michael Weiss
President, Chief Executive Officer, Director
James Oliviero
Chief Financial Officer, Treasurer, Corporate Secretary
William Gray
Director
Lindsay Rosenwald
Independent Director
Christian Bechon

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$69.6M
Revenue (TTM)
$68.0K
Shares Outstanding
36.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.23
EPS
$-2.37
Book Value
$-0.47
P/E Ratio
-0.8x
Price/Sales (TTM)
1,024.2
Price/Cash Flow (TTM)
---
Operating Margin
-66,195.59%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.